What is the appropriate initial empiric antibiotic regimen for a patient with a one‑week fever, leukocytosis (white blood cell count 18,040/µL, neutrophils 54%), elevated alanine aminotransferase (ALT 111 U/L), severe hypertension (200/110 mmHg), unknown infection source, and normal renal function?

Empiric Antibiotic Recommendation

Initiate broad-spectrum IV antibiotics immediately with an extended-spectrum β-lactam (such as ceftriaxone 2g IV or cefepime 2g IV) within one hour of recognition, given this patient's presentation consistent with possible sepsis (fever, leukocytosis with neutrophilia, elevated ALT, severe hypertension). 1

Clinical Reasoning

This patient presents with:

• One-week fever with significant leukocytosis (WBC 18,040/µL, 54% neutrophils)
• Elevated ALT (111 U/L, approximately 3-5× ULN based on updated reference ranges)
• Severe hypertension (200/110 mmHg) suggesting systemic inflammatory response
• Unknown infection source

While the patient doesn't meet all classic sepsis criteria, the constellation of prolonged fever, marked leukocytosis, and organ dysfunction (hepatic involvement) warrants aggressive empiric therapy following sepsis guidelines.

Specific Antibiotic Selection

First-line options:

• Ceftriaxone 2g IV daily - provides broad gram-positive and gram-negative coverage, excellent tissue penetration
• Cefepime 2g IV every 8-12 hours - fourth-generation cephalosporin with broader gram-negative coverage including Pseudomonas

The Surviving Sepsis Campaign guidelines mandate IV antimicrobials within one hour for suspected sepsis, using broad-spectrum agents covering all likely pathogens with adequate tissue penetration 1.

Critical Actions Before Antibiotics

Obtain blood cultures (minimum 2 sets, aerobic and anaerobic) before antibiotic administration, but do NOT delay antibiotics beyond 45 minutes 1. The one-hour window is non-negotiable for mortality reduction.

Source Identification

Look specifically for:

• Intra-abdominal source (given elevated ALT - consider biliary pathology, hepatic abscess)
• Urinary tract infection (check urinalysis, urine culture)
• Pneumonia (chest imaging if not already done)
• Skin/soft tissue infection (examine for cellulitis, abscess)

The elevated ALT suggests possible hepatobiliary involvement or systemic inflammatory response affecting the liver. Consider abdominal imaging (ultrasound or CT) urgently if no other source identified 1.

Important Caveats

Do NOT add vancomycin empirically unless:

• Patient has indwelling vascular catheters
• Known MRSA colonization
• Severe skin/soft tissue infection visible on exam
• Hemodynamic instability develops

Do NOT use combination therapy (β-lactam + aminoglycoside or fluoroquinolone) for this patient who is not in frank septic shock and is not neutropenic 1.

Reassessment Timeline

• At 48-72 hours: Reassess based on culture results and clinical response
• De-escalate to narrower spectrum once pathogen identified 1
• If no improvement at 72 hours: Broaden coverage, consider adding anaerobic coverage or antifungal therapy, repeat imaging

Duration

Plan for 7-10 days total once source identified and patient clinically improving 1. This may extend if bacteremia with S. aureus identified or if undrained focus persists.

Blood Pressure Management

The severe hypertension (200/110 mmHg) requires urgent but careful management alongside antibiotics - avoid precipitous drops that could compromise organ perfusion during potential sepsis. Target MAP ≥65 mmHg while gradually controlling hypertension.